About Atreus Pharmaceuticals
Atreus Pharmaceuticals is a company based in Ottawa (Canada) founded in 2007 was acquired by Advanced Accelerator Applications in January 2015.. Atreus Pharmaceuticals has raised $6 million across 1 funding round from investors including Advanced Accelerator Applications. Atreus Pharmaceuticals operates in a competitive market with competitors including ImaginAb, AC Immune, HYCOR BioMedical, APRINOIA and Innovate Biopharma, among others.
- Headquarter Ottawa, Canada
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6 M (USD)
in 1 rounds
-
Latest Funding Round
$6 M (USD), Series A
Mar 02, 2010
- Investors
-
Employee Count
Employee Count
-
Acquired by
Advanced Accelerator Applications
(Jan 08, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Atreus Pharmaceuticals
Atreus Pharmaceuticals has successfully raised a total of $6M through 1 strategic funding round. The most recent funding activity was a Series A round of $6 million completed in March 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $6.0M
-
First Round
First Round
(02 Mar 2010)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2010 | Amount | Series A - Atreus Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Atreus Pharmaceuticals
Atreus Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Advanced Accelerator Applications. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Atreus Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Atreus Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Atreus Pharmaceuticals Comparisons
Competitors of Atreus Pharmaceuticals
Atreus Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ImaginAb, AC Immune, HYCOR BioMedical, APRINOIA and Innovate Biopharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| domain | founded_year | HQ Location |
Antibodies, small molecules, and vaccines are developed for neurodegenerative diseases.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic instruments and reagents for autoimmune diseases and allergies
|
|
| domain | founded_year | HQ Location |
Diagnostics and therapeutics for neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule drugs and imaging agent for GI disorders
|
|
| domain | founded_year | HQ Location |
Imaging compounds & targeted radiotherapies to detect and treat prostate cancer.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Atreus Pharmaceuticals
When was Atreus Pharmaceuticals founded?
Atreus Pharmaceuticals was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Where is Atreus Pharmaceuticals located?
Atreus Pharmaceuticals is headquartered in Ottawa, Canada. It is registered at Ottawa, Ontario, Canada.
Is Atreus Pharmaceuticals a funded company?
Atreus Pharmaceuticals is a funded company, having raised a total of $6M across 1 funding round to date. The company's 1st funding round was a Series A of $6M, raised on Mar 02, 2010.
What does Atreus Pharmaceuticals do?
Atreus Pharmaceuticals was focussed on developing in-vivo radiopharmaceutical products for Nuclear Medicine (SPECT) imaging and for PET imaging. Its product line was based on the Annexin V human protein, which binds to phosphatidylserine, a molecule that only shows up on the surface of dead or dying cells. Its lead diagnostic product Annexin V-128 was in phase 12 trials for rheumatoid arthritis and ankylosing spondylitis. It also claims that the compound when used with the medical isotope Technetium-99, has the ability to be used to evaluate the response to treatment for lymphoma and lung cancer. In January 2015, Advanced Accelerator Applications (AAA) fully acquired Atreus.
Who are the top competitors of Atreus Pharmaceuticals?
Who are Atreus Pharmaceuticals's investors?
Atreus Pharmaceuticals has 1 investor. Key investors include Advanced Accelerator Applications.